Status: current, Defined. Date: 31-Mar 2021. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4536411000168115 | Abrilada (adalimumab 40 mg / 0.8 mL) injection, 0.8 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4536421000168110 | Abrilada 40 mg/0.8 mL injection, 0.8 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Abrilada 40 mg/0.8 mL injection, 0.8 mL syringe | Is a | Abrilada | true | Inferred relationship | Some | ||
Abrilada 40 mg/0.8 mL injection, 0.8 mL syringe | Is a | adalimumab 40 mg/0.8 mL injection, syringe | true | Inferred relationship | Some | ||
Abrilada 40 mg/0.8 mL injection, 0.8 mL syringe | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Abrilada 40 mg/0.8 mL injection, 0.8 mL syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
Abrilada 40 mg/0.8 mL injection, 0.8 mL syringe | has unit of use | syringe | true | Inferred relationship | Some | 587931057 | |
Abrilada 40 mg/0.8 mL injection, 0.8 mL syringe | has Australian BoSS | adalimumab | true | Inferred relationship | Some | 1158442050 | |
Abrilada 40 mg/0.8 mL injection, 0.8 mL syringe | has intended active ingredient | adalimumab | true | Inferred relationship | Some | 1158442050 |
Reference Sets
Trade product unit of use reference set